Telephone
1.802.861.7745
Address
Suite 210 120 Kimball Avenue South Burlington, VT 05403
Description
Mach7 Technologies Ltd. engages in the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. It operates through the following geographical segments: North America, Asia Pacific, Middle East, and Europe and Other Regions. The company was founded by Ravi Krishnan in 2007 and is headquartered in South Burlington, VT.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.52 - 0.99
Trade Value (12mth)
AU$33,082.00
1 week
-3.45%
1 month
-1.41%
YTD
4.48%
1 year
23.89%
All time high
719.392
EPS 3 yr Growth
-540.000%
EBITDA Margin
5.50%
Operating Cashflow
-$3m
Free Cash Flow Return
-4.40%
ROIC
-1.70%
Interest Coverage
24.90
Quick Ratio
2.30
Shares on Issue (Fully Dilluted)
240m
HALO Sector
Technology
Next Company Report Date
28-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.08
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 11 |
Safety Medical Products Limited - Notice of Annual General Meeting/Proxy Form (SFP-AU)
×
Safety Medical Products Limited - Notice of Annual General Meeting/Proxy Form (SFP-AU) |
31 March 23 |
Amendment to Appendix 3Y - ES
×
Amendment to Appendix 3Y - ES |
31 March 16 |
3D Medical Limited - EGM Presentation by CEO of Mach7 Technologies (3DM-AU)
×
3D Medical Limited - EGM Presentation by CEO of Mach7 Technologies (3DM-AU) |
31 July 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 July 23 |
Change in substantial holding
×
Change in substantial holding |
31 July 18 |
CEO Presentation to Shareholders - General Meeting
×
CEO Presentation to Shareholders - General Meeting |
31 January 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 August 23 |
Preliminary Final Report and Audited Financial Statements
×
Preliminary Final Report and Audited Financial Statements |
31 August 23 |
FY23 Results Highlights
×
FY23 Results Highlights |
31 August 23 |
Investor Presentation FY2023 Results
×
Investor Presentation FY2023 Results |
31 August 12 |
Safety Medical Products Limited - Annual Financial Report to shareholder (SFP-AU)
×
Safety Medical Products Limited - Annual Financial Report to shareholder (SFP-AU) |
30 September 22 |
Change of Director's Interest Notice - ML
×
Change of Director's Interest Notice - ML |
30 September 13 |
Safety Medical Products Limited - Annual Report to shareholders (SFP-AU)
×
Safety Medical Products Limited - Annual Report to shareholders (SFP-AU) |
30 September 11 |
Safety Medical Products Limited - Annual Report to shareholders (SFP-AU)
×
Safety Medical Products Limited - Annual Report to shareholders (SFP-AU) |
30 October 20 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
30 October 17 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 October 17 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 November 20 |
Mach7 AGM 2020 Presentation
×
Mach7 AGM 2020 Presentation |
30 November 20 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
30 November 17 |
CEO's presentation to shareholders at 2017 AGM
×
CEO's presentation to shareholders at 2017 AGM |
30 November 17 |
Results of 2017 Annual General Meeting
×
Results of 2017 Annual General Meeting |
30 November 11 |
Safety Medical Products Limited - Results of Annual General Meeting (SFP-AU)
×
Safety Medical Products Limited - Results of Annual General Meeting (SFP-AU) |
30 November 09 |
Results of Annual General Meeting (SFP-AU)
×
Results of Annual General Meeting (SFP-AU) |
30 March 11 |
Safety Medical Products Limited - Results of Annual General Meeting (SFP-AU)
×
Safety Medical Products Limited - Results of Annual General Meeting (SFP-AU) |
30 January 23 |
Change in substantial holding
×
Change in substantial holding |
29 September 22 |
Appendix 4G
×
Appendix 4G |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.